vs
Ascendis Pharma A/S（ASND）与Rocket Lab Corp（RKLB）财务数据对比。点击上方公司名可切换其他公司
Ascendis Pharma A/S的季度营收约是Rocket Lab Corp的1.5倍（$267.3M vs $179.7M），Ascendis Pharma A/S同比增速更快（42.3% vs 35.7%），过去两年Ascendis Pharma A/S的营收复合增速更高（60.7% vs 39.2%）
Ascendis Pharma A/S是一家聚焦内分泌疾病治疗领域的生物制药企业，核心业务覆盖生长激素疗法的研发、生产与商业化。其依托重组DNA技术生产的生长激素类处方药物，可用于治疗多种生长激素缺乏相关适应症，临床应用场景广泛。
Rocket Lab是公开上市的航空航天制造商及发射服务提供商，旗下Electron轨道火箭主打小型卫星发射，截至2026年1月已成功完成超75次任务，是全球现役发射次数最多的小型运载火箭。公司还开发了Electron的亚轨道改型HASTE用作高超音速技术测试平台，下一代可复用中型运载火箭Neutron目前也在研发中。
ASND vs RKLB — 直观对比
营收规模更大
ASND
是对方的1.5倍
$179.7M
营收增速更快
ASND
高出6.6%
35.7%
两年增速更快
ASND
近两年复合增速
39.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $267.3M | $179.7M |
| 净利润 | — | $-52.9M |
| 毛利率 | 90.5% | 38.0% |
| 营业利润率 | — | -28.4% |
| 净利率 | — | -29.5% |
| 营收同比 | 42.3% | 35.7% |
| 净利润同比 | — | -1.1% |
| 每股收益（稀释后） | — | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASNDRKLB
| Q4 25 | $267.3M | $179.7M | ||
| Q3 25 | $230.7M | $155.1M | ||
| Q2 25 | $170.7M | $144.5M | ||
| Q1 25 | $109.0M | $122.6M | ||
| Q4 24 | $187.8M | $132.4M | ||
| Q3 24 | $62.5M | $104.8M | ||
| Q2 24 | $38.9M | $106.3M | ||
| Q1 24 | $103.6M | $92.8M |
净利润ASNDRKLB
| Q4 25 | — | $-52.9M | ||
| Q3 25 | $-65.9M | $-18.3M | ||
| Q2 25 | $-42.0M | $-66.4M | ||
| Q1 25 | $-102.2M | $-60.6M | ||
| Q4 24 | — | $-52.3M | ||
| Q3 24 | $-107.1M | $-51.9M | ||
| Q2 24 | $-118.1M | $-41.6M | ||
| Q1 24 | $-141.5M | $-44.3M |
毛利率ASNDRKLB
| Q4 25 | 90.5% | 38.0% | ||
| Q3 25 | 89.5% | 37.0% | ||
| Q2 25 | 80.1% | 32.1% | ||
| Q1 25 | 82.6% | 28.8% | ||
| Q4 24 | 91.9% | 27.8% | ||
| Q3 24 | 80.6% | 26.7% | ||
| Q2 24 | 68.2% | 25.6% | ||
| Q1 24 | 92.1% | 26.1% |
营业利润率ASNDRKLB
| Q4 25 | — | -28.4% | ||
| Q3 25 | 5.1% | -38.0% | ||
| Q2 25 | -33.5% | -41.3% | ||
| Q1 25 | -103.2% | -48.3% | ||
| Q4 24 | — | -38.9% | ||
| Q3 24 | -167.3% | -49.5% | ||
| Q2 24 | -370.2% | -40.7% | ||
| Q1 24 | -51.2% | -46.4% |
净利率ASNDRKLB
| Q4 25 | — | -29.5% | ||
| Q3 25 | -28.5% | -11.8% | ||
| Q2 25 | -24.6% | -46.0% | ||
| Q1 25 | -93.7% | -49.5% | ||
| Q4 24 | — | -39.5% | ||
| Q3 24 | -171.5% | -49.6% | ||
| Q2 24 | -303.9% | -39.2% | ||
| Q1 24 | -136.6% | -47.7% |
每股收益（稀释后）ASNDRKLB
| Q4 25 | — | $-0.09 | ||
| Q3 25 | — | $-0.03 | ||
| Q2 25 | — | $-0.13 | ||
| Q1 25 | — | $-0.12 | ||
| Q4 24 | — | $-0.11 | ||
| Q3 24 | — | $-0.10 | ||
| Q2 24 | — | $-0.08 | ||
| Q1 24 | — | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $665.3M | $1.0B |
| 总债务越低越好 | — | $152.4M |
| 股东权益账面价值 | $-175.8M | $1.7B |
| 总资产 | $1.4B | $2.3B |
| 负债/权益比越低杠杆越低 | — | 0.09× |
8季度趋势，按日历期对齐
现金及短期投资ASNDRKLB
| Q4 25 | $665.3M | $1.0B | ||
| Q3 25 | $582.2M | $976.7M | ||
| Q2 25 | $533.6M | $688.1M | ||
| Q1 25 | $559.4M | $428.4M | ||
| Q4 24 | $604.3M | $419.0M | ||
| Q3 24 | $675.6M | $442.4M | ||
| Q2 24 | $279.4M | $496.8M | ||
| Q1 24 | $345.9M | $492.5M |
总债务ASNDRKLB
| Q4 25 | — | $152.4M | ||
| Q3 25 | — | $347.0M | ||
| Q2 25 | — | $346.5M | ||
| Q1 25 | — | $345.9M | ||
| Q4 24 | — | $345.4M | ||
| Q3 24 | — | $61.2M | ||
| Q2 24 | — | $64.2M | ||
| Q1 24 | — | $66.8M |
股东权益ASNDRKLB
| Q4 25 | $-175.8M | $1.7B | ||
| Q3 25 | $-188.0M | $1.3B | ||
| Q2 25 | $-202.6M | $688.5M | ||
| Q1 25 | $-205.0M | $431.3M | ||
| Q4 24 | $-114.2M | $382.5M | ||
| Q3 24 | $-105.1M | $419.8M | ||
| Q2 24 | $-346.8M | $455.2M | ||
| Q1 24 | $-257.2M | $478.9M |
总资产ASNDRKLB
| Q4 25 | $1.4B | $2.3B | ||
| Q3 25 | $1.2B | $2.2B | ||
| Q2 25 | $1.2B | $1.6B | ||
| Q1 25 | $1.1B | $1.3B | ||
| Q4 24 | $1.3B | $1.2B | ||
| Q3 24 | $1.2B | $1.2B | ||
| Q2 24 | $819.0M | $1.2B | ||
| Q1 24 | $866.7M | $1.2B |
负债/权益比ASNDRKLB
| Q4 25 | — | 0.09× | ||
| Q3 25 | — | 0.27× | ||
| Q2 25 | — | 0.50× | ||
| Q1 25 | — | 0.80× | ||
| Q4 24 | — | 0.90× | ||
| Q3 24 | — | 0.15× | ||
| Q2 24 | — | 0.14× | ||
| Q1 24 | — | 0.14× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $58.2M | $-64.5M |
| 自由现金流经营现金流 - 资本支出 | — | $-114.2M |
| 自由现金流率自由现金流/营收 | — | -63.6% |
| 资本支出强度资本支出/营收 | — | 27.6% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-321.8M |
8季度趋势，按日历期对齐
经营现金流ASNDRKLB
| Q4 25 | $58.2M | $-64.5M | ||
| Q3 25 | — | $-23.5M | ||
| Q2 25 | — | $-23.2M | ||
| Q1 25 | $-15.5M | $-54.2M | ||
| Q4 24 | $-330.7M | $-2.4M | ||
| Q3 24 | — | $-30.9M | ||
| Q2 24 | — | $-13.0M | ||
| Q1 24 | $-109.7M | $-2.6M |
自由现金流ASNDRKLB
| Q4 25 | — | $-114.2M | ||
| Q3 25 | — | $-69.4M | ||
| Q2 25 | — | $-55.3M | ||
| Q1 25 | — | $-82.9M | ||
| Q4 24 | — | $-23.9M | ||
| Q3 24 | — | $-41.9M | ||
| Q2 24 | — | $-28.3M | ||
| Q1 24 | — | $-21.8M |
自由现金流率ASNDRKLB
| Q4 25 | — | -63.6% | ||
| Q3 25 | — | -44.8% | ||
| Q2 25 | — | -38.3% | ||
| Q1 25 | — | -67.6% | ||
| Q4 24 | — | -18.1% | ||
| Q3 24 | — | -40.0% | ||
| Q2 24 | — | -26.7% | ||
| Q1 24 | — | -23.5% |
资本支出强度ASNDRKLB
| Q4 25 | — | 27.6% | ||
| Q3 25 | — | 29.6% | ||
| Q2 25 | — | 22.2% | ||
| Q1 25 | — | 23.4% | ||
| Q4 24 | — | 16.3% | ||
| Q3 24 | — | 10.5% | ||
| Q2 24 | — | 14.4% | ||
| Q1 24 | — | 20.7% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASND
暂无分部数据
RKLB
| Products | $94.0M | 52% |
| Transferred Over Time | $87.3M | 49% |
